|
Management of Multiple Myeloma: Smoldering, Newly Diagnosed, and Relapsed/Refractory Disease |
2.25 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
An Interactive Case-Based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates |
2.00 |
12/20/2024 - 12:00am to 12/20/2025 - 12:00am |
|
Caring for Patients With Cancer in a Post-COVID World: Expert Guidance on the Latest Data and Therapeutic Advances to Mitigate Infection Risk |
1.50 |
07/23/2024 - 12:00am to 07/23/2025 - 12:00am |
|
Applying NCCN Guidelines for the Treatment of CLL/SLL in Clinical Practice: The Right Agent for the Right Patient at the Right Time |
1.50 |
07/23/2024 - 12:00am to 07/23/2025 - 12:00am |
|
Are You Applying the Latest Guidelines for Multiple Myeloma? Experts Discuss Equitable, Evidence-Based Care |
1.50 |
01/31/2025 - 12:00am to 01/31/2026 - 12:00am |
|
Myeloma Masterclass: Applying the Latest Guidelines for Evidence-Based, Equitable Care |
1.50 |
05/31/2025 - 9:00pm to 07/02/2025 - 12:00am |
|
Expert Perspectives on Updates and Advances in Individualizing CLL/SLL Therapy Across the Disease Course |
1.50 |
05/29/2025 - 9:00pm to 07/01/2025 - 12:00am |
|
Plenary Session: Artificial Intelligence in Cancer Care: Opportunities, Challenges, and Governance |
1.25 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Advances in the Management of Metastatic Breast Cancer with SABCS Updates |
1.25 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Neoadjuvant/Adjuvant Treatment of Early-Stage Breast Cancer with SABCS Updates |
1.25 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
Plenary Session: Addressing Mental Health in Cancer Care: Optimizing Interdisciplinary Psychosocial Support |
1.25 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
NCCN Guidelines® Insights - Myelodysplastic Syndromes, Version 2.2025 |
1.00 |
03/10/2025 - 12:00am to 03/10/2026 - 12:00am |
|
Advances in the Treatment of Non-Metastatic Non-Small Cell Lung Cancer |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Management of Immune Checkpoint Inhibitor-Related Toxicities |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Recorded Presentation from Optimizing Patient Outcomes - Beyond the Package Insert: Appropriate Interpretation of Testing Results for Targeted... |
1.00 |
03/10/2025 - 12:00am to 03/10/2026 - 12:00am |
Facebook
Twitter
LinkedIn
Forward